Insulin effects on myocardial function and bioenergetics in L-bupivacaine toxicity in the isolated rat heart

European Journal of Anaesthesiology

Volumn 24, Issue 4, 2007, Pages 340-346

  Stehr, Sebastian N ^a,b   Pexa, A ^a   Hannack, S ^a   Heintz, A ^a   Heller, A R ^a   Deussen, A ^a   Koch, T ^a   Hubler M ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Adenosine triphosphate; Anaesthetics local, bupivacaine, toxicity; Drug toxicity; Heart; Insulin

Indexed keywords

ADENINE NUCLEOTIDE DERIVATIVE; BUPIVACAINE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INOTROPISM; ISOLATED HEART; NONHUMAN; PR INTERVAL; QRS COMPLEX; RAT; SYSTOLIC BLOOD PRESSURE;

ADENINE NUCLEOTIDES; ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; ELECTROCARDIOGRAPHY; ENERGY METABOLISM; HEART; HEART RATE; INSULIN; RATS; RATS, WISTAR;

EID: 33847048278     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506002109     Document Type: Article

References (28)

1. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979; 51: 285-287.
2. Weinberg GL. Current concepts in resuscitation of patients with local anesthetic cardiac toxicity. Reg Anesth Pain Med 2002; 27: 568-575.
3. Cho HS, Lee JJ, Chung IS, Shin BS, Kim JA, Lee KH. Insulin reverses bupivacaine-induced cardiac depression in dogs. Anesth Analg 2000; 91: 1096-1102.
4. Kim JT, Jung CW, Lee KH. The effect of insulin on the resuscitation of bupivacaine-induced severe cardiovascular toxicity in dogs. Anesth Analg 2004; 99: 728-733.
5. Weinberg G, VadeBoncouer T. Improved energetics may explain the favorable effect of insulin infusion on bupivacaine cardiotoxicity. Anesth Analg 2001; 92: 1075-1076.
6. Mather LE, Chang DH. Cardiotoxicity with modern local anaesthetics: is there a safer choice? Drugs 2001; 61: 333-342.
7. Grupp IL, Subramaniam A, Hewett TE, Robbins J, Grupp G. Comparison of normal, hypodynamic, and hyperdynamic mouse hearts using isolated work-performing heart preparations. Am J Physiol 1993; 265: H1401-H1410.
8. Sutherland FJ, Hearse DJ. The isolated blood and perfusion fluid perfused heart. Pharmacol Res 2000; 41: 613-627.
9. Haink G, Deussen A. Liquid chromatography method for the analysis of adenosine compounds. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 784: 189-193.
10. Himsworth RL. Hypothalamic control of adrenaline secretion in response to insufficient glucose. J Physiol 1970; 206: 411-417.
11. Burmester MD, Schluter KD, Daut J, Hanley PJ. Enantioselective actions of bupivacaine and ropivacaine on coronary vascular resistance at cardiotoxic concentrations. Anesth Analg 2005; 100: 707-712.
12. Graf BM, Martin E, Bosnjak ZJ, Stowe DF. Stereospecific effect of bupivacaine isomers on atrioventricular conduction in the isolated perfused guinea pig heart. Anesthesiology 1997; 86: 410-419.
13. Zapata-Sudo G, Trachez MM, Sudo RT, Nelson TE. Is comparative cardiotoxicity of S(2) and R(1) bupivacaine related to enantiomer-selective inhibition of L-type Ca(21) channels? Anesth Analg 2001; 92: 496-501.
14. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563-569.
15. Mather LE, Long GJ, Thomas J. The intravenous toxicity and clearance of bupivacaine in man. Clin Pharmacol Ther 1971; 12: 935-943.
16. Bardsley H, Gristwood R, Baker H,Watson N, Nimmo W. A comparison of the cardiovascular effects of levobupivacaine and rac-bupivacaine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 1998; 46: 245-249.
17. Rieker RP, Lee JC, Downing SE. Positive inotropic action of insulin on piglet heart. Yale J Biol Med 1975; 48: 353-359.
18. Airaksinen J, Lahtela JT, Ikaheimo MJ, Sotaniemi EA, Takkunen JT. Intravenous insulin has no effect on myocardial contractility or heart rate in healthy subjects. Diabetologia 1985; 28: 649-652.
19. Lee JC, Downing SE. Effects of insulin on cardiac muscle contraction and responsiveness to norepinephrine. Am J Physiol 1976; 230: 1360-1365.
20. Tune JD, Mallet RT, Downey HF. Insulin improves cardiac contractile function and oxygen utilization efficiency during moderate ischemia without compromising myocardial energetics. J Mol Cell Cardiol 1998; 30: 2025-2035.
21. Gupta MP, Lee SL, Dhalla NS. Activation of heart sarcoplasmic reticulum Ca++-stimulated adenosine tri-phosphatase by insulin. J Pharmacol Exp Ther 1989; 249: 623-630.
22. Gupta MP, Makino N, Khatter K, Dhalla NS. Stimulation of Na+-Ca2+ exchange in heart sarcolemma by insulin. Life Sci 1986; 39: 1077-1083.
23. Ballard C, Mozaffari M, Schaffer S. Signal transduction mechanism for the stimulation of the sarcolemmal Na(+)- Ca2+ exchanger by insulin. Mol Cell Biochem 1994; 135: 113-119.
24. Schmidt HD, Koch M. Influence of perfusate calcium concentration on the inotropic insulin effect in isolated guinea pig and rat hearts. Basic Res Cardiol 2002; 97: 305-311.
25. Tanz RD, Heskett T, Loehning RW, Fairfax CA. Comparative cardiotoxicity of bupivacaine and lidocaine in the isolated perfused mammalian heart. Anesth Analg 1984; 63: 549-556.
26. Butterworth JF, Brownlow RC, Leith JP, Prielipp RC, Cole LR. Bupivacaine inhibits cyclic-3′,5′-adenosine monophosphate production. A possible contributing factor to cardiovascular toxicity. Anesthesiology 1993; 79: 88-95.
27. Rossner KL, Freese KJ. Bupivacaine inhibition of L-type calcium current in ventricular cardiomyocytes of hamster. Anesthesiology 1997; 87: 926-934.
28. Mio Y, Fukuda N, Kusakari Y, Tanifuji Y, Kurihara S. Bupivacaine attenuates contractility by decreasing sensitivity of myofilaments to Ca2+ in rat ventricular muscle. Anesthesiology 2002; 97: 1168-1177.